The immunogenicity and protection effect of the BPL-inactivated CA16 vaccine in different animal systems

References

• Chan LG, Parashar UD, Lye MS, Ong FG, Zaki SR, Alexander JP, Ho KK, Han LL, Pallansch MA, Suleiman AB, et al, For the Outbreak Study Group. Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. Clin Infect Dis 2000; 31:678 - 83; http://dx.doi.org/10.1086/314032; PMID: 11017815
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Deaths among children during an outbreak of hand, foot, and mouth disease--Taiwan, Republic of China, April-July 1998. MMWR Morb Mortal Wkly Rep 1998; 47:629 - 32; PMID: 9704628
   PubMedGoogle Scholar
• Pallansch M, Roos R. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses, p 839–93 In Knipe DM, et al., editors. (ed), Fields virology, 5th ed Lippincott Williams & Wilkins, Philadelphia, PA.
   Google Scholar
• Zhu J, Luo Z, Wang J, Xu Z, Chen H, Fan D, Gao N, Ping G, Zhou Z, Zhang Y, et al. Phylogenetic analysis of Enterovirus 71 circulating in Beijing, China from 2007 to 2009. PLoS One 2013; 8:e56318; http://dx.doi.org/10.1371/journal.pone.0056318; PMID: 23418551
   PubMedGoogle Scholar
• Huang XY, Kang K, Xu YL, Wei HY, Li XL, Ma H, You AG, Chen HM, Xu BL. [Etiology surveillance of hand-foot-mouth disease in Henan province between 2008 and 2011]. Zhonghua Yu Fang Yi Xue Za Zhi 2012; 46:883 - 7; PMID: 23363860
   PubMedGoogle Scholar
• Christensen A, Nordbø SA. [Enterovirus infections diagnosed in middle Norway during the period 1992-2001]. Tidsskr Nor Laegeforen 2003; 123:3180 - 3; PMID: 14714003
   PubMedGoogle Scholar
• Kusuda H, Kitamura S. Localization of coxsackie A16 viral antigen in various organs of newborn mice by the fluorescent antibody technique. Jpn J Microbiol 1974; 18:411 - 3; http://dx.doi.org/10.1111/j.1348-0421.1974.tb00828.x; PMID: 4613901
   PubMedGoogle Scholar
• Sickles GM, Mutterer M, Feorino P, Plager H. Recently classified types of Coxsackie virus, group A; behavior in tissue culture. Proc Soc Exp Biol Med 1955; 90:529 - 31; http://dx.doi.org/10.3181/00379727-90-22088; PMID: 13273503
   PubMed Web of Science ®Google Scholar
• Oberste MS, Peñaranda S, Maher K, Pallansch MA. Complete genome sequences of all members of the species Human enterovirus A. J Gen Virol 2004; 85:1597 - 607; http://dx.doi.org/10.1099/vir.0.79789-0; PMID: 15166444
   PubMed Web of Science ®Google Scholar
• Pöyry T, Hyypiä T, Horsnell C, Kinnunen L, Hovi T, Stanway G. Molecular analysis of coxsackievirus A16 reveals a new genetic group of enteroviruses. Virology 1994; 202:982 - 7; http://dx.doi.org/10.1006/viro.1994.1423; PMID: 8030260
   PubMed Web of Science ®Google Scholar
• Wang CY, Li Lu F, Wu MH, Lee CY, Huang LM. Fatal coxsackievirus A16 infection. Pediatr Infect Dis J 2004; 23:275 - 6; http://dx.doi.org/10.1097/01.inf.0000115950.63906.78; PMID: 15014311
   PubMed Web of Science ®Google Scholar
• Xu W, Liu CF, Yan L, Li JJ, Wang LJ, Qi Y, Cheng RB, Xiong XY. Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications. Virol J 2012; 9:8; http://dx.doi.org/10.1186/1743-422X-9-8; PMID: 22230340
   PubMed Web of Science ®Google Scholar
• Chen CW, Lee YP, Wang YF, Yu CK. Formaldehyde-inactivated human enterovirus 71 vaccine is compatible for co-immunization with a commercial pentavalent vaccine. Vaccine 2011; 29:2772 - 6; http://dx.doi.org/10.1016/j.vaccine.2011.01.094; PMID: 21315698
   PubMed Web of Science ®Google Scholar
• Ong KC, Devi S, Cardosa MJ, Wong KT. Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease. J Virol 2010; 84:661 - 5; http://dx.doi.org/10.1128/JVI.00999-09; PMID: 19864378
   PubMed Web of Science ®Google Scholar
• Polley JR, Guerin MM. The use of beta-propiolactone for the preparation of virus vaccines. I. Selection of reaction conditions. Can J Microbiol 1957; 3:863 - 70; http://dx.doi.org/10.1139/m57-095; PMID: 13472511
   PubMed Web of Science ®Google Scholar
• Polley JR, Guerin MM. The use of beta-propiolactone for the preparation of virus vaccines. II. Antigenicity. Can J Microbiol 1957; 3:871 - 7; http://dx.doi.org/10.1139/m57-096; PMID: 13472512
   PubMed Web of Science ®Google Scholar
• Iwai M, Masaki A, Hasegawa S, Obara M, Horimoto E, Nakamura K, Tanaka Y, Endo K, Tanaka K, Ueda J, et al. Genetic changes of coxsackievirus A16 and enterovirus 71 isolated from hand, foot, and mouth disease patients in Toyama, Japan between 1981 and 2007. Jpn J Infect Dis 2009; 62:254 - 9; PMID: 19628900
   PubMed Web of Science ®Google Scholar
• Ranganathan S, Singh S, Poh CL, Chow VT. The hand, foot and mouth disease virus capsid: sequence analysis and prediction of antigenic sites from homology modelling. Appl Bioinformatics 2002; 1:43 - 52; PMID: 15130856
   PubMedGoogle Scholar
• Reed LJ, Muench H. A simple method of estimating 50 percent end-points. Am J Hyg 1938; 27:493 - 7
   Google Scholar
• Bek EJ, Hussain KM, Phuektes P, Kok CC, Gao Q, Cai F, Gao Z, McMinn PC. Formalin-inactivated vaccine provokes cross-protective immunity in a mouse model of human enterovirus 71 infection. Vaccine 2011; 29:4829 - 38; http://dx.doi.org/10.1016/j.vaccine.2011.04.070; PMID: 21550375
   PubMed Web of Science ®Google Scholar
• Kamaraj G, Lakshmi Narasu M, Srinivasan VA. Validation of betapropiolactone (BPL) as an inactivant for infectious bovine rhinotracheitis (IBR) virus. Res Vet Sci 2008; 85:589 - 94; http://dx.doi.org/10.1016/j.rvsc.2007.12.009; PMID: 18262212
   PubMed Web of Science ®Google Scholar
• Refaie FM, Esmat AY, Mohamed AF, Mohamed WA. The effect of chemical inactivation of bovine viral diarrhea virus with beta-propiolactone and binary ethyleneimine on plasma proteins and coagulation factors. Egypt J Immunol 2004; 11:9 - 20; PMID: 16734113
   PubMedGoogle Scholar
• Cai Y, Liu Q, Huang X, Li D, Ku Z, Zhang Y, Huang Z. Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection. Vaccine 2013; 31:2215 - 21; http://dx.doi.org/10.1016/j.vaccine.2013.03.007; PMID: 23499596
   PubMed Web of Science ®Google Scholar
• Liu Q, Yan K, Feng Y, Huang X, Ku Z, Cai Y, Liu F, Shi J, Huang Z. A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge. Vaccine 2012; 30:6642 - 8; http://dx.doi.org/10.1016/j.vaccine.2012.08.071; PMID: 22959985
   PubMed Web of Science ®Google Scholar
• Herrlich A, Epp C, Mayr A. [Animal experimental studies on various smallpox vaccines in a cowpox challenge experiment on white mice]. Z Immunitatsforsch Allerg Klin Immunol 1968; 135:237 - 45; PMID: 4301159
   PubMedGoogle Scholar
• Dong C, Wang J, Liu L, Zhao H, Shi H, Zhang Y, Jiang L, Li Q. Optimized development of a candidate strain of inactivated EV71 vaccine and analysis of its immunogenicity in rhesus monkeys. Hum Vaccin 2010; 6:1028 - 37; http://dx.doi.org/10.4161/hv.6.12.12982; PMID: 21150270
   PubMed Web of Science ®Google Scholar
• Mao Q, Li N, Yu X, Yao X, Li F, Lu F, Zhuang H, Liang Z, Wang J. Antigenicity, animal protective effect and genetic characteristics of candidate vaccine strains of enterovirus 71. Arch Virol 2012; 157:37 - 41; http://dx.doi.org/10.1007/s00705-011-1136-3; PMID: 21984267
   PubMed Web of Science ®Google Scholar
• Mao Q, Wang Y, Gao R, Shao J, Yao X, Lang S, Wang C, Mao P, Liang Z, Wang J. A neonatal mouse model of coxsackievirus A16 for vaccine evaluation. J Virol 2012; 86:11967 - 76; http://dx.doi.org/10.1128/JVI.00902-12; PMID: 22951825
   PubMed Web of Science ®Google Scholar
• Liu CC, Lian WC, Butler M, Wu SC. High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture. Vaccine 2007; 25:19 - 24; http://dx.doi.org/10.1016/j.vaccine.2006.06.083; PMID: 16919374
   PubMed Web of Science ®Google Scholar
• Quesney S, Marvel J, Marc A, Gerdil C, Meignier B. Characterization of Vero cell growth and death in bioreactor with serum-containing and serum-free media. Cytotechnology 2001; 35:115 - 25; http://dx.doi.org/10.1023/A:1017589526145; PMID: 19003288
   PubMed Web of Science ®Google Scholar
• Dong C, Liu L, Zhao H, Wang J, Liao Y, Zhang X, Na R, Liang Y, Wang L, Li Q. Immunoprotection elicited by an enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeys. Vaccine 2011; 29:6269 - 75; http://dx.doi.org/10.1016/j.vaccine.2011.06.044; PMID: 21722686
   PubMed Web of Science ®Google Scholar